These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4074825)

  • 1. Testing for a trend in tumor prevalence rates: I. Nonlethal tumors.
    Dinse GE
    Biometrics; 1985 Sep; 41(3):751-70. PubMed ID: 4074825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Ryan LM
    Biometrics; 1985 Jun; 41(2):525-31. PubMed ID: 4027327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity.
    Bieler GS; Williams RL
    Biometrics; 1993 Sep; 49(3):793-801. PubMed ID: 8241374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of false positive rates of peto and poly-3 methods for long-term carcinogenicity data analysis using multiple comparison adjustment method suggested by Lin and Rahman.
    Rahman MA; Lin KK
    J Biopharm Stat; 2008; 18(5):949-58. PubMed ID: 18781527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples.
    Bailer AJ; Portier CJ
    Biometrics; 1988 Jun; 44(2):417-31. PubMed ID: 3390507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An age-adjusted bootstrap-based Poly-k test.
    Moon H; Ahn H; Kodell RL
    Stat Med; 2005 Apr; 24(8):1233-44. PubMed ID: 15573413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of test procedures for multidose animal carcinogenicity assays under competing risks.
    Graves TS
    J Biopharm Stat; 1994 Nov; 4(3):289-320. PubMed ID: 7881450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Gart JJ; Tarone RE
    Biometrics; 1987 Mar; 43(1):235-44. PubMed ID: 3567308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing equality of relative survival patterns based on aggregated data.
    Hakulinen T; Tenkanen L; Abeywickrama K; Päivärinta L
    Biometrics; 1987 Jun; 43(2):313-25. PubMed ID: 3607203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonparametric tests of tumor prevalence data.
    Sun J; Kalbfleisch JD
    Biometrics; 1996 Jun; 52(2):726-31. PubMed ID: 8672708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment.
    Finkelstein DM
    Biometrics; 1991 Jun; 47(2):669-80. PubMed ID: 1912266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of k for the poly-k test with application to animal carcinogenicity studies.
    Moon H; Ahn H; Kodell RL; Lee JJ
    Stat Med; 2003 Aug; 22(16):2619-36. PubMed ID: 12898548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of multiple tumor data from a rodent carcinogenicity experiment.
    Finkelstein DM; Schoenfeld DA
    Biometrics; 1989 Mar; 45(1):219-30. PubMed ID: 2720052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing approaches for overdispersion in poisson regression versus the generalized poisson model.
    Yang Z; Hardin JW; Addy CL; Vuong QH
    Biom J; 2007 Aug; 49(4):565-84. PubMed ID: 17638291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of historical controls in time-adjusted trend tests for carcinogenicity.
    Ibrahim JG; Ryan LM
    Biometrics; 1996 Dec; 52(4):1478-85. PubMed ID: 8962464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized tumor rates for chronic bioassays.
    Kodell RL; Gaylor DW; Chen JJ
    Biometrics; 1986 Dec; 42(4):867-73. PubMed ID: 3814727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.